Drugs
Search by drug name or a recorded alias for a verified drug. Open its page to see linked trials and published FDA events.
N-803 + Nivolumab
Drug identity checked against registry
N-803 + Nivolumab + PD-L1 t-haNK
Drug identity checked against registry
N-803 + Pembrolizumab
Drug identity checked against registry
N-803 + Pembrolizumab + PD-L1 t-haNK
Drug identity checked against registry
N-803 and BCG
Drug identity checked against registry
N-803 and Gemcitabine
Drug identity checked against registry
NAI + Nivolumab + Ipilimumab
Drug identity checked against registry
NAI + Pembrolizumab
Drug identity checked against registry
NAI + Pembrolizumab + Carboplatin + Nab-paclitaxel or Paclitaxel
Drug identity checked against registry
NAL ER
Drug identity checked against registry
NB-UVB phototherapy active treatment
Drug identity not yet verified
NB-UVB phototherapy sham treatment
Drug identity not yet verified
NDV-01 (sustained-release gemcitabine-docetaxel)
Drug identity checked against registry
NDV01 intravesical controlled release formulation of gemcitabine and docetaxel
Drug identity checked against registry
NE3107
Drug identity checked against registry
NEO100
Drug identity checked against registry
NGN-401
Drug identity not yet verified
NKTR-255 at 1.5 µg/kg
Drug identity checked against registry
NKTR-255 at 3.0 μg/kg
Drug identity checked against registry
NKTR-255 at 3.0/6.0 μg/kg
Drug identity checked against registry
NMRA-335140
Drug identity checked against registry
NMRA-335140 80 mg
Drug identity checked against registry
NRTI
Drug identity checked against registry
NS2 Ophthalmic Drops (0.5%)
Drug identity checked against registry
NS2 Ophthalmic Drops Vehicle (0.0%)
Drug identity checked against registry
NTLA-2001
Drug identity checked against registry
NTLA-2002
Drug identity checked against registry
NVX-CoV2373
Drug identity checked against registry
NVX-CoV2373 (5μg)
Drug identity checked against registry
NVX-CoV2373 + NVX-CoV2515
Drug identity checked against registry